A failure-to-warn plaintiff in Georgia must show that the product carried a non-obvious risk, that the manufacturer knew or should have known of the risk, that the manufacturer failed to provide an adequate warning, and that the absence of a warning was a proximate cause of the plaintiff’s injury. Causation in failure-to-warn cases requires a showing that the plaintiff would have read and heeded an adequate warning if one had been provided. This heeding presumption is sometimes available to plaintiffs but is contested by defendants who argue that the plaintiff would have ignored a warning even if given. Georgia courts have not uniformly adopted a formal heeding presumption (which would presume the plaintiff would have read and followed an adequate warning), though some Georgia decisions have applied a rebuttable inference in the plaintiff’s favor. The adequacy of the warning that was provided, including its placement, clarity, and prominence, is typically a central dispute. Georgia courts also recognize a post-sale duty to warn: when a manufacturer learns of a previously unknown risk after the product is sold, the manufacturer may have a duty to issue supplemental warnings or recalls. This duty is particularly relevant in cases involving medical devices, pharmaceuticals, and industrial equipment where post-market safety data reveals risks that were not apparent at the time of sale.
65.1. What is the heeding presumption in Georgia failure-to-warn cases, and how does the defendant rebut it?
The heeding presumption creates a rebuttable inference that the plaintiff would have read and followed an adequate warning if one had been provided. This presumption shifts the burden to the defendant to show that the plaintiff would have disregarded the warning. Defendants rebut the presumption through evidence that the plaintiff had a history of ignoring warnings, that the plaintiff was aware of the risk through other sources, or that the plaintiff’s conduct demonstrated a pattern of disregarding safety instructions.
65.2. How does Georgia define an adequate warning in terms of content, placement, and prominence?
An adequate warning must convey the nature and severity of the risk in clear, understandable language. It must be placed where the user will see it at the time of use, not buried in a lengthy manual that the user is unlikely to read. The warning must be prominent enough to attract the user’s attention, using appropriate font size, color coding, or graphic symbols. Warnings about severe risks require greater prominence than warnings about minor hazards.
65.3. What role does the plaintiff’s literacy, language, or education level play in evaluating warning adequacy in Georgia?
The adequacy of a warning is generally evaluated from the perspective of a reasonably foreseeable user of the product. If the manufacturer knows or should know that the product will be used by populations with limited literacy or non-English speakers, the warning must be designed to communicate effectively to those users. Pictograms, multilingual warnings, and simplified language may be required when the foreseeable user population includes individuals who cannot read standard English warnings.
65.4. How does Georgia treat failure-to-warn claims when the plaintiff was already aware of the risk that materialized?
If the plaintiff was already aware of the specific risk that caused the injury, the failure to warn may not have been the proximate cause of the injury because an additional warning would not have changed the plaintiff’s behavior. The defendant argues that the warning’s absence was irrelevant because the plaintiff already possessed the information the warning would have conveyed. The plaintiff’s prior knowledge must be specific to the risk that materialized, not merely a general awareness that the product could be dangerous.
65.5. Can a manufacturer satisfy its warning duty in Georgia by providing warnings only to the initial purchaser?
When a product is likely to be used by persons other than the initial purchaser, the manufacturer’s warning duty may extend to foreseeable downstream users. Providing warnings only to the initial purchaser may be insufficient if the manufacturer knows the product will be used by others who will not receive the warning. This issue commonly arises with industrial equipment, power tools, and products that are resold or shared among users.
65.6. How does Georgia handle post-sale duty to warn when a manufacturer learns of a new risk after the product is already in the market?
Georgia recognizes a post-sale duty to warn when the manufacturer learns of a risk that was not known at the time of sale. The manufacturer must take reasonable steps to inform users of the newly discovered danger. Reasonable steps may include issuing recall notices, sending direct communications to registered owners, publishing warnings, and notifying retailers and distributors. The adequacy of the post-sale warning effort is evaluated based on the severity of the risk and the feasibility of reaching affected users.
65.7. What expert testimony is required to establish that a different warning would have prevented the plaintiff’s injury in Georgia?
Expert testimony is used to establish what an adequate warning would have said, how it would have been presented, and whether a user who received that warning would have acted differently. Human factors experts testify about warning design, placement, and communication effectiveness. The plaintiff’s experts must bridge the gap between the hypothetical adequate warning and the plaintiff’s likely response to it. The defendant’s experts challenge the assumption that the plaintiff would have heeded any warning regardless of its content or format.
65.8. How does Georgia treat failure-to-warn claims in cases involving prescription drugs where the learned intermediary doctrine applies?
Under the learned intermediary doctrine, a pharmaceutical manufacturer’s duty to warn runs to the prescribing physician rather than directly to the patient. If the manufacturer provided adequate warnings to the physician, the manufacturer has satisfied its duty even if the patient was unaware of the risks. The physician, as the learned intermediary, is expected to evaluate the warnings and exercise professional judgment in prescribing. The doctrine may not apply when the manufacturer engaged in direct-to-consumer advertising that bypassed the physician.
Disclaimer: This content is provided for informational and educational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this material. Georgia law is subject to change through new legislation and court decisions. Always consult a qualified Georgia attorney for advice specific to your situation.